DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
Growing evidence suggests that cisplatin and other chemotherapeutic agents promote tumor metastasis while inhibiting tumor growth, which is a critical issue for certain patients in clinical practices. However, the role of chemotherapeutics in promoting tumor metastasis and the molecular mechanism in...
Main Authors: | Xiaosu Chen, Yajing Lv, Kejia Xu, Xiaoshuang Wang, Yujia Zhao, Jia Li, Xuan Qin, Yi Shi, Longlong Wang, Antao Chang, Chongbiao Huang, Rong Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/6/1403 |
Similar Items
-
DCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance
by: Pan Xie, et al.
Published: (2021-05-01) -
Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-03-01) -
miR‐15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2
by: Jun Wang, et al.
Published: (2020-06-01) -
Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity
by: Xinyue Song, et al.
Published: (2021-06-01) -
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
by: Wang J, et al.
Published: (2020-09-01)